Trial · NCT01839084
Registered outcomes15
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 15 of 15
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Evaluation of the impact of xenon-anesthesia on the renal function after partial nephrectomy, compared to an isoflurane-anesthesia. | Within the first 7 postoperative days | Evaluation of the maximum decrease of glomerular filtration rate (GFR) within 7 days after partial nephrectomy surgery. Maximum decrease will be assessed by the difference between the baseline value of GFR and the minimum value of GFR after surgery. |
| Secondary | Secondary efficacy criteria for using xenon-anaesthesia during partial nephrectomy. | Intraoperatively | Ischaemia time |
| Secondary | Secondary efficacy criteria for using xenon-anaesthesia during partial nephrectomy. | Intraoperatively | Duration of xenon/isoflurane exposition before and after the kidney ischemia time. |
| Secondary | Secondary efficacy criteria for using xenon-anaesthesia during partial nephrectomy. | Intraoperatively until discharge from hospital | Tumor size and histology, if applicable detection of hypoxia-inducible factor 1α (HIF-1α) in healthy resection border tissue |
| Secondary | Secondary efficacy criteria for using xenon-anaesthesia during partial nephrectomy. | Intraoperatively and within the first 7 postoperative days | Measurement of macrophage migration inhibitory factor (MIF) in serum |
| Secondary | Secondary efficacy criteria for using xenon-anaesthesia during partial nephrectomy. | preaoperativ and Within the first 7 postoperative days | Course of GFR determined with the Cystatin C value in serum |
| Secondary | Secondary efficacy criteria for using xenon-anaesthesia during partial nephrectomy. | preaoperativ and Within the first 7 postoperative days | Course of creatinine value in serum |
| Secondary | Secondary efficacy criteria for using xenon-anaesthesia during partial nephrectomy. | Within the first 7 postoperative days | Urine output within the first 48houres after surgery |
| Secondary | Secondary efficacy criteria for using xenon-anaesthesia during partial nephrectomy. | Within the first 7 postoperative days | If applicable determination of kidney injury molecule-1 (KIM-1)or neutrophil gelatinase-associated lipocalin (NGAL) |
| Secondary | Secondary efficacy criteria for using xenon-anaesthesia during partial nephrectomy. | Within the first 7 postoperative days | Determination of acute kidney failure according to the AKIN classification |
| Secondary | Safety criteria for using xenon-anaesthesia during partial nephrectomy. | intraoperative | Doses and concentration of study treatments |
| Secondary | Safety criteria for using xenon-anaesthesia during partial nephrectomy. | intraoperative and within the first 7 postoperative days | The peri-anaesthetic respiratory profile |
| Secondary | Safety criteria for using xenon-anaesthesia during partial nephrectomy. | intraoperative and within the first 7 postoperative days | The peri-anaesthetic haemodynamic profile |
| Secondary | Safety criteria for using xenon-anaesthesia during partial nephrectomy. | intraoperative | Intra-operative blood loss |
| Secondary | Safety criteria for using xenon-anaesthesia during partial nephrectomy. | intraoperative and within the first 7 postoperative days | The incidence of adverse event (AE) and serious adverse event (SAE) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01839084/registered